Brussels [Belgium], May 21 (ANI): According to new research by the scientific congress of the European Society of Cardiology, life-threatening arrhythmias are more common on days with highly polluted air (ESC).

Hyderabad Jan 28 PTI Dr Reddys Laboratories on Friday said it is in discussions with the Indian drug regulator to bring Russias Sputnik M a COVID-19 vaccine for the 12 to18-year-old category to India Addressing a press conference after announcing the companys Q3 results a senior executive of the drug maker said Phase 3 clinical trial data of Russias single dose COVID-19 vaccine Sputnik Light has been submitted to the regulator and is awaiting approval Deepak Sapra CEO API and Services Dr Reddys also said the company is fully geared to make Molnupiravir a COVID-19 drug both API and Formulations at its facilities even as it approached World Health organization for the prequalification of the drug Sputnik M is a sputnik for adolescents In Russia Sputnik M has been given the approval by the regulator for children in the 12 to 18 years old group The same data has been made available here We are in the process of translating the data and we will be having a conversation with the regulator on this data within the next few months Sapra told reporters He further said the company may probably conduct another round of clinical trials in India if the Indian regulator says so Russian Direct Investment Fund RDIF last month said it has applied for the registration of Sputnik M to the Indian regulator for approval The sovereign wealth fund said Russias Health Ministry registered Sputnik M on November 24 2021 Replying to query he said the clinical trials for the Sputnik Light in India are over and the data was submitted to the Drug Controller General of India It has demonstrated efficacy which is consistent and in line with the result that we have seen in the global trials which we have conducted in Russia What we conducted in India is safety and immunogenicity studies Sapra said On Molnupiravir the official said in this current wave Omicron is the dominant variant and it has seen relatively lower hospitalizations However the company will continue to be ready for the COVID-19 drug to be made available for India and 103 countries for which it has rights PTI GDK BN BN BN

India on Monday got a pat on the back from the World Health Organisation as the country’s cumulative vaccination coverage against Covid-19 surpassed the 75 crore-mark.  The WHO South-East Asia regional director Dr Poonam Khetrapal Singh congratulated India for achieving the feat at an ‘unprecedented pace.’In a tweet Dr Khetrapal quoted as saying that while it took 85 days to administer the […]

pThe Mexican President Andres Manuel Lopez Obrador used Portuguese striker Cristiano Ronaldo as a symbol and an example at his countrys campaign to fight obesity during a news conference he gavep